Jindong Sheng
52 Fucheng Road
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
SFRP2 drives aerobic glycolysis and tumor progression in ovarian cancer by transcriptional upregulation of PTK2B.
Journal: Journal of translational medicine
Published: January 09, 2026
Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencing.
Journal: Cancer treatment and research communications
Published: August 17, 2025
Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.
Journal: Signal transduction and targeted therapy
Published: October 28, 2024
RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.
Journal: Journal of cellular and molecular medicine
Published: July 19, 2023
Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer.
Journal: Frontiers in genetics
Published: December 03, 2021
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer.
Journal: Frontiers in immunology
Published: December 03, 2021
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
Journal: Cell death & disease
Published: December 01, 2021
Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy.
Journal: International journal of nanomedicine
Published: December 31, 2020
Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel-sensitive and docetaxel-resistant castration-resistant prostate cancer cells.
Journal: Journal of cellular and molecular medicine
Published: May 12, 2020
Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
Journal: The Prostate
Published: February 07, 2019
Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8 + T cells in benign prostatic hyperplasia.
Journal: The Prostate
Published: February 07, 2019
Last Updated: 09/26/2026